• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    CareCloud Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits

    9/16/24 4:30:31 PM ET
    $CCLD
    Computer Software: Prepackaged Software
    Technology
    Get the next $CCLD alert in real time by email
    false --12-31 0001582982 0001582982 2024-09-11 2024-09-11 0001582982 CCLD:CommonStockParValue0.001PerShareMember 2024-09-11 2024-09-11 0001582982 CCLD:Sec8.75SeriesCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember 2024-09-11 2024-09-11 0001582982 CCLD:Sec8.75SeriesBCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember 2024-09-11 2024-09-11 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the

    Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): September 11, 2024

     

    CARECLOUD, INC.

    (Exact name of registrant as specified in its charter)

     

    Delaware   001-36529   22-3832302

    (State or other jurisdiction

    of incorporation)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

     

    7 Clyde Road, Somerset, New Jersey, 08873

    (Address of principal executive offices, zip code)

     

    (732) 873-5133

    (Registrant’s telephone number, including area code)

     

    Not Applicable

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common Stock, par value $0.001 per share   CCLD   Nasdaq Global Market
    8.75% Series A Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share   CCLDP   Nasdaq Global Market
    8.75% Series B Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share   CCLDO   Nasdaq Global Market

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    Item 3.03 Material Modification to Rights of Security Holders.

     

    The information set forth in Item 5.03 of this Current Report on Form 8-K is incorporated by reference herein.

     

    Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

     

    Ninth Amendment to Certificate of Designations of Series A Preferred Stock

     

    On September 11, 2024, CareCloud, Inc. (the “Company”) filed a Ninth Amendment (the “Amendment”) to the Amended and Restated Certificate of Designations, Preferences and Rights (the “Series A Certificate of Designations”) of 11% Series A Cumulative Redeemable Perpetual Preferred Stock with the Secretary of State of the State of Delaware which was effective upon filing. The following are the provisions that were amended to the Existing Certificate:

     

      A. The title of the Existing Certificate is hereby amended to read in its entirety as follows:

     

    CARECLOUD, INC.

    AMENDED AND RESTATED CERTIFICATE OF DESIGNATIONS,

    PREFERENCES AND RIGHTS OF 8.75% SERIES A CUMULATIVE REDEEMABLE

    PERPETUAL PREFERRED STOCK,

    AS AMENDED

     

      B. Paragraph 1 of the Existing Certificate (Designation and Amount) is hereby amended to read in its entirety as follows:

     

      1. Designation and Amount. The shares of such series of Preferred Stock shall be designated as “8.75% Series A Cumulative Redeemable Perpetual Preferred Stock” and the number of shares constituting such series shall be 4,526,231 shares.

     

      C. Paragraph 4 of the Existing Certificate (Dividends) is hereby amended so that (i) all references to the per annum dividend rate is amended from 11% to 8.75% per annum, and (ii) all references per annum dividend amount per share is amended from $2.75 to $2.1875 per share per annum.

     

    2

     

     

      D. Paragraph 6 of the Existing Certificate (Redemption) is hereby amended so that:

     

      (I) The following two sentences are added to the end of Paragraph 6(c) of the Existing Certificate:

     

    If the Corporation does not elect to redeem shares of Series A Preferred Stock as described in this Section 6(c), holders of Series A Preferred Stock may, upon written notice to the Corporation, exchange some or all of the shares of Series A Preferred Stock held by such holder into a number of shares of Common Stock per share of Series A Preferred Stock equal to the quotient obtained by dividing (1) the sum of the $25.00 per share liquidation preference plus the amount of any accumulated and unpaid dividends by (2) the Common Stock Price for such Change of Control.

     

    The “Common Stock Price” for any Change of Control will be: (i) if the consideration to be received in the Change of Control by the holders of Common Stock is solely cash, the amount of cash consideration per share of Common Stock; and (ii) if the consideration to be received in the Change of Control by holders of Common Stock is other than solely cash, or if consideration cannot be determined or no consideration is received by holders of Common Stock (x) the average of the closing prices for Common Stock on the principal U.S. securities exchange on which Common Stock is then traded (or, if no closing sale price is reported, the average of the closing bid and ask prices per share or, if more than one in either case, the average of the average closing bid and the average closing ask prices per share) for the ten consecutive trading days immediately preceding, but not including, the date on which such Change of Control occurred as reported on the principal U.S. securities exchange on which Common Stock is then traded, or (y) the average of the last quoted bid prices for Common Stock in the over-the-counter market as reported by OTC Markets Group Inc. or similar organization for the ten consecutive trading days immediately preceding, but not including, the date on which such Change of Control occurred, if Common Stock is not then listed for trading on a U.S. securities exchange.

     

      (II) The definition of “Change of Control” is hereby amended by adding the following clause at the end Paragraph 6(d) of the Existing Certificate: “or, alternatively, Series A Preferred Stock is no longer listed on the NYSE, the NYSE MKT or the Nasdaq, or listed or quoted on an exchange or quotation system that is a successor to the NYSE, the NYSE MKT or Nasdaq.”
         
      (III) The following clause is inserted in Paragraph 6(k) of the Existing Certificate: “, except as set forth in Section 6(c) with respect to the right of holders of Series A Preferred Stock to exchange their shares of Series A Preferred Stock” so that Paragraph 6(k) reads in its entirety as follows:

     

    (k) Unless full cumulative dividends on all shares of Series A Preferred Stock shall have been or contemporaneously are declared and paid or declared and a sum sufficient for the payment thereof has been or contemporaneously is set apart for payment for all past dividend periods, no shares of Series A Preferred Stock shall be redeemed unless all outstanding shares of Series A Preferred Stock are simultaneously redeemed and, except as set forth in Section 6(c) with respect to the right of holders of Series A Preferred Stock to exchange their shares of Series A Preferred Stock, the Corporation shall not purchase or otherwise acquire directly or indirectly any shares of Series A Preferred Stock (except by exchanging it for its capital stock ranking junior to the Series A Preferred Stock as to the payment of dividends, or the distribution of assets upon liquidation, dissolution, or winding up); provided, however, that the foregoing shall not prevent the purchase or acquisition by the Corporation of shares of Series A Preferred Stock pursuant to a purchase or exchange offer made on the same terms to holders of all outstanding shares of Series A Preferred Stock.

     

    3

     

     

      E. Paragraph 7 of the Existing Certificate is hereby amended to read in its entirety as follows:

     

    7. Mandatory Exchange.

     

    (a) The Corporation shall have the right, at its option, to cause the outstanding shares of the Series A Preferred Stock, in whole or in part, at any time or from time to time, to be automatically exchanged for a number of shares of Common Stock (the “Exchange Shares”) per share of Series A Preferred Stock equal to the quotient obtained by dividing (1) the sum of (a) the $25.00 per share liquidation preference, and (b) the amount of any accumulated and unpaid dividends on such share being exchanged by (2) the Exchange Price.

     

    (b) The “Exchange Price” shall be the volume weighted average price of the shares of Common Stock traded on the Nasdaq Global Market, or any other national securities exchange on which the shares of Common Stock are then traded (or if such volume-weighted average price is unavailable, the market value of one share of the Common Stock determined, using a volume-weighted average method, by a nationally recognized independent investment banking firm retained for this purpose by the Corporation) for the twenty trading days ending on the first trading day immediately preceding the Mandatory Exchange Date.

     

    (c) To exercise the mandatory exchange right described in Section 7(a), the Corporation must issue a press release for publication on the Dow Jones News Service or Bloomberg Business News (or if neither service is available, another broadly disseminated news or press release service selected by the Corporation) announcing such mandatory exchange. The Corporation shall also provide written notice to all the holders of the Series A Preferred Stock no later than the date of the press release of the Corporation’s election to mandatorily exchange the Series A Preferred Stock. The exchange date in connection with a mandatory exchange (the “Mandatory Exchange Date”) shall be the date on which the Corporation issues the press release described in this Section 7(c).

     

    (d) In addition to any information required by applicable law or regulation, the press release shall state, as appropriate: (i) the Mandatory Exchange Date; (ii) the number of Exchange Shares to be issued upon exchange of each share of Series A Preferred Stock; and (iii) that dividends on the Series A Preferred Stock to be exchanged will cease to accrue on the Mandatory Exchange Date.

     

    (e) Except as otherwise expressly provided for herein, upon the occurrence of a mandatory exchange described in Section 7(a), the holders of the Series A Preferred Stock shall, upon notice from the Corporation, surrender their shares of Series A Preferred Stock at the offices of the Corporation or its transfer agent for the Common Stock. As soon as practicable thereafter (but in any event within 10 Business Days), the Corporation shall issue and deliver to such holder the number of Exchange Shares into which the shares of Series A Preferred Stock so surrendered were exchangeable on the Mandatory Exchange Date.

     

    (f) On and after the Mandatory Exchange Date, dividends shall cease to accrue on the Series A Preferred Stock called for a mandatory exchange pursuant to this Section 7 and all rights of holders of such Series A Preferred Stock shall terminate except for the right to receive the Exchange Shares with such adjustment for fractional shares set forth in Section 7(g). The full amount of any dividend payment with respect to the Series A Preferred Stock for which the relevant Mandatory Exchange Date occurs during the period beginning on, and including, any Dividend Record Date for a declared dividend and ending on, and including, the corresponding Dividend Payment Date shall be payable on such Dividend Payment Date to the record holder of such share at the close of business on such Dividend Record Date notwithstanding the mandatory exchange of such Series A Preferred Stock. Except as provided in the immediately preceding sentence with respect to a mandatory exchange pursuant to Section 7, no payment or adjustment shall be made upon exchange of Series A Preferred Stock for accumulated dividends thereon or dividends with respect to the Common Stock issued upon such exchange thereof.

     

    4

     

     

    (g) No fractional shares of Common Stock or scrip representing fractional shares shall be issued upon the exchange of shares of Series A Preferred Stock. Instead of any fractional shares of Common Stock which would otherwise be issuable upon exchange of Series A Preferred Stock, the Corporation shall round up to the next whole share of Common Stock issuable upon the exchange of shares of Series A Preferred Stock. The determination as to whether any fractional shares of Common Stock shall be rounded up shall be made with respect to the aggregate number of shares of Series A Preferred Stock held by a holder and being exchanged at any one time, not with respect to each share of Series A Preferred Stock held by such holder being exchanged, so that no more than one rounded share of Common Stock shall be issued to a holder in any one exchange.

     

    (h) If less than all of the outstanding Series A Preferred Stock is to be exchanged, the Series A Preferred Stock to be exchanged shall be selected pro rata (as nearly as may be practicable without creating fractional shares) or by any other equitable method the Corporation shall determine.

     

    (i) If the Common Stock issuable upon the exchange of the Series A Preferred Stock shall be changed into the same or different number of shares of any class or classes of capital stock, whether by capital reorganization, recapitalization, reclassification or otherwise (other than a merger, consolidation, sale of all or substantially all of the Corporation’s assets to any other person or the disposition of more than 50% of the voting power of the Corporation), then and in each such event the Corporation shall have the right thereafter to exchange each share of Series A Preferred Stock into the kind and amount of shares of capital stock and other securities and property receivable upon such reorganization, recapitalization, reclassification or other change by the holders of the number of shares of Common Stock into which such shares of Series A Preferred Stock might have been exchanged immediately prior to such reorganization, recapitalization, reclassification or change, all subject to further adjustment as provided herein.

     

    (j) Notwithstanding anything in this Section 7 to on the contrary, any mandatory exchange pursuant to this Section 7 shall only be effected to the extent permitted and also in accordance with all applicable laws, rules and regulations, including the Delaware General Corporation Law, federal securities laws, and the applicable listing rules for any U.S. securities exchange for which the Corporation has listed its Series A Preferred Stock and/or Common Stock.

     

    (k) Further notwithstanding anything in this Section 7 to the contrary, the Corporation shall not exercise its mandatory exchange right described in Section 7 herein relative to the Series A Preferred Stock of any individual shareholders who, as of the Mandatory Exchange Date: (i) own at least 100,000 shares of Series A Preferred Stock (“Material Shareholder”); and (ii) provide written notice to the Corporation at its principal corporate address, within seven days of the Mandatory Conversion Date, that they object to the exchange of their Series A Preferred Stock. For clarity, in the event that any Material Shareholders object to the Exchange, all other shares of Series A Preferred Stock owned by other shareholders shall be exchanged as provided for in Section 7; however, all shares of Series A Preferred Stock owned by the objecting Material Shareholders shall remain outstanding and the terms set forth in Sections 7(a) through 7(j) shall not apply to said shares

     

    The foregoing description of the Certificate of Designations does not purport to be complete and is qualified in its entirety by reference to the Certificate of Designations, a copy of which is included as Exhibit 3.1 to this Current Report on Form 8-K and incorporated by reference herein.

     

    5

     

     

    Item 7.01 Regulation FD Disclosure.

     

    The information furnished pursuant to Item 7.01 of this Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Exchange Act or the Securities Act of 1933, as amended or the Exchange Act, except as expressly set forth by specific reference in such a filing.

     

    Safe Harbor Statement

     

    Statements contained in the exhibits that state the Registrant’s or its management’s expectations or predictions of the future are forward-looking statements intended to be covered by the safe harbor provisions of the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended. It is important to note that the Registrant’s actual results could differ materially from those projected in such forward-looking statements. The Registrant does not assume any obligations to update any of the forward-looking statements contained in the exhibits to reflect events that occur or circumstances that exist after the date on which they were made.

     

    Item 9.01 Financial Statements and Exhibits.

     

    Exhibit No.   Description
         
    3.1   Ninth Amendment to Amended and Restated Certificate of Designations, Preferences and Rights of 11% Series A Cumulative Redeemable Perpetual Preferred Stock.
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

    6

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      CareCloud, Inc.
         
    Date: September 16, 2024 By: /s/ A. Hadi Chaudhry
        A. Hadi Chaudhry
        Chief Executive Officer

     

    7

    Get the next $CCLD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CCLD

    DatePrice TargetRatingAnalyst
    11/13/2024$5.00 → $3.50Buy → Neutral
    ROTH MKM
    More analyst ratings

    $CCLD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CareCloud to Announce Fourth Quarter and Full Year 2025 Results on March 12, 2026

    SOMERSET, N.J., Feb. 19, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)) ("CareCloud" or the "Company"), a leader in AI-powered healthcare technology and revenue cycle management solutions for medical practices and health systems nationwide, will release its financial results for the fourth quarter and full year ended December 31, 2025 before the market opens on Thursday, March 12, 2026. The Company will follow with a conference call for investors at 8:30 a.m. Eastern Time. The live webcast of the conference call and related presentation slides can be accessed at ir.carecloud.com/events. An audio-only option is available by dialing 201-389-0920 and referencing "CareCloud, I

    2/19/26 8:00:00 AM ET
    $CCLD
    Computer Software: Prepackaged Software
    Technology

    Memorial Hospital Selects CareCloud's HealthLine to Drive Supply Chain Efficiency and Inventory Integrity

    SOMERSET, N.J., Jan. 29, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)) ("CareCloud" or the "Company"), a leader in healthcare technology and AI-powered solutions, today announced the signing of Memorial Hospital in Marysville, Ohio for its HealthLine supply chain management platform. The agreement brings CareCloud's comprehensive clinical supply chain solution to a community healthcare system committed to operational excellence and resource stewardship. The HealthLine platform entered the CareCloud product portfolio through its acquisition of Medsphere in August 2025, adding a nationally recognized supply chain management system to complement CareCloud's AI-driven ambulat

    1/29/26 8:00:00 AM ET
    $CCLD
    Computer Software: Prepackaged Software
    Technology

    CareCloud's Wellsoft Ranked #1 EHR by Black Book 2026 for Emergency Medicine

    SOMERSET, N.J., Jan. 22, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)) ("CareCloud" or the "Company"), a leader in healthcare technology and AI-powered solutions, today announced that Black Book Research has recognized the Company's Wellsoft Emergency Department Information System ("EDIS") in its 2026 Emergency Medicine specialty ranking as the top-rated EHR for Emergency Medicine. The recognition highlights Wellsoft's ED-ready workflow speed, throughput visibility, and operational reliability in high-acuity care environments. "Wellsoft was purpose-built for emergency medicine, where speed, visibility, and reliability are not optional," said Chris Langehaug, Senior Vice P

    1/22/26 8:00:00 AM ET
    $CCLD
    Computer Software: Prepackaged Software
    Technology

    $CCLD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    CareCloud downgraded by ROTH MKM with a new price target

    ROTH MKM downgraded CareCloud from Buy to Neutral and set a new price target of $3.50 from $5.00 previously

    11/13/24 7:36:28 AM ET
    $CCLD
    Computer Software: Prepackaged Software
    Technology

    $CCLD
    SEC Filings

    View All

    CareCloud Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - CareCloud, Inc. (0001582982) (Filer)

    1/20/26 8:10:48 AM ET
    $CCLD
    Computer Software: Prepackaged Software
    Technology

    CareCloud Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - CareCloud, Inc. (0001582982) (Filer)

    12/29/25 4:30:36 PM ET
    $CCLD
    Computer Software: Prepackaged Software
    Technology

    CareCloud Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits

    8-K - CareCloud, Inc. (0001582982) (Filer)

    11/26/25 5:00:46 PM ET
    $CCLD
    Computer Software: Prepackaged Software
    Technology

    $CCLD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Sharnak Lawrence Steven converted options into 7,500 shares, increasing direct ownership by 6% to 127,750 units (SEC Form 4)

    4 - CareCloud, Inc. (0001582982) (Issuer)

    2/10/26 9:30:07 PM ET
    $CCLD
    Computer Software: Prepackaged Software
    Technology

    Director Busquet Anne converted options into 7,500 shares, increasing direct ownership by 3% to 295,138 units (SEC Form 4)

    4 - CareCloud, Inc. (0001582982) (Issuer)

    2/10/26 9:30:04 PM ET
    $CCLD
    Computer Software: Prepackaged Software
    Technology

    Director Munter Cameron converted options into 7,500 shares, increasing direct ownership by 4% to 202,750 units (SEC Form 4)

    4 - CareCloud, Inc. (0001582982) (Issuer)

    2/10/26 9:30:06 PM ET
    $CCLD
    Computer Software: Prepackaged Software
    Technology

    $CCLD
    Financials

    Live finance-specific insights

    View All

    CareCloud to Announce Fourth Quarter and Full Year 2025 Results on March 12, 2026

    SOMERSET, N.J., Feb. 19, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)) ("CareCloud" or the "Company"), a leader in AI-powered healthcare technology and revenue cycle management solutions for medical practices and health systems nationwide, will release its financial results for the fourth quarter and full year ended December 31, 2025 before the market opens on Thursday, March 12, 2026. The Company will follow with a conference call for investors at 8:30 a.m. Eastern Time. The live webcast of the conference call and related presentation slides can be accessed at ir.carecloud.com/events. An audio-only option is available by dialing 201-389-0920 and referencing "CareCloud, I

    2/19/26 8:00:00 AM ET
    $CCLD
    Computer Software: Prepackaged Software
    Technology

    CareCloud Announces Preferred Stock Dividend Payments

    SOMERSET, N.J., Jan. 20, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. ("CareCloud" or the "Company") (NASDAQ:CCLD, CCLDO)), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, announced today that its Board of Directors (the "Board") has declared monthly cash dividends for its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock ("Series A Preferred Stock") and its 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock ("Series B Preferred Stock") for January, February and March 2026. With respect to the Series B Preferred Stock only, the Board has declared an additional dividend payment to be paid for January, Fe

    1/20/26 8:00:00 AM ET
    $CCLD
    Computer Software: Prepackaged Software
    Technology

    CareCloud Announces Plan to Pay Double Monthly Dividends on its Series B Preferred Stock Beginning in January 2026

    Plan Based on Growing Recurring Revenues and Margins; Double Dividends Expected to Continue until Series B Dividend Arrears are Fully Satisfied SOMERSET, N.J., Nov. 10, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)) ("CareCloud" or the "Company") today announced that its Board of Directors has adopted a formal plan (the "Plan") to satisfy the 14 months of accumulated and unpaid dividends (i.e., those dividends that accumulated from November 2023 through December 2024) on its 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock ("Series B Preferred Stock") (NASDAQ:CCLDO). The Company is pleased to announce this Plan based on its successful turnaround and confidenc

    11/10/25 8:00:00 AM ET
    $CCLD
    Computer Software: Prepackaged Software
    Technology

    $CCLD
    Leadership Updates

    Live Leadership Updates

    View All

    CareCloud Appoints Chief Strategy Officer to Lead Enterprise AI Platform as Company Enters 2026 as Its Defining AI Year

    Strategic leadership alignment positions CareCloud to scale execution, expand margins, and accelerate AI-driven innovation across ambulatory and hospital markets SOMERSET, N.J., Dec. 29, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)), ("CareCloud" or the "Company") a leader in healthcare technology and AI-powered solutions, today announced leadership promotions designed to align the organization for its next phase of growth and to position 2026 as a defining year for enterprise AI innovation across the Company's platform. Effective January 1, 2026, A. Hadi Chaudhry will serve as Chief Strategy Officer, leading CareCloud's enterprise AI vision, platform innovation, and com

    12/29/25 8:00:00 AM ET
    $CCLD
    Computer Software: Prepackaged Software
    Technology

    CareCloud Announces Results from Annual Shareholders' Meeting

    Shareholders Re-Elect 3 Board Members, Approve the Compensation for the Company's Named Executives and Approve the Appointment of Public Accounting Firm SOMERSET, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO)), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced that it held its 2025 Annual Shareholders' Meeting on May 27, 2025, during which shareholders re-elected Anne Busquet, Bill Korn and Lawrence Sharnak for another two-year term. Shareholders also voted to approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's 20

    5/28/25 8:05:00 AM ET
    $CCLD
    Computer Software: Prepackaged Software
    Technology

    CareCloud Acquires RevNu Medical Management, Completing Second Acquisition in 31 Days

    SOMERSET, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO)), a leading provider of practice management, healthcare technology and AI-driven solutions to medical practices across the country, today announced the acquisition of RevNu Medical Management ("RevNu"), an emerging audiology-focused revenue cycle management ("RCM") company based in Westminster, California. "We've spent years building trusted relationships within the audiology community, and we couldn't be more excited to join forces with CareCloud," said Clay Gililland, founder of RevNu. "That experience has given us a deep understanding of the industry's needs—insights we're excited to

    4/2/25 9:00:00 AM ET
    $CCLD
    Computer Software: Prepackaged Software
    Technology